Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in GALT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $5.5M | β | 2.986% | 0.00% |
| 2 | MARSHALL WACE, LLP | 1.2M | $3.4M | +102.6% | 1.852% | 0.00% |
| 3 | ADVISOR GROUP HOLDINGS, INC. | 1.1M | $3.1M | +2.9% | 1.705% | 0.00% |
| 4 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.1M | $3.0M | +21.7% | 1.630% | 0.00% |
| 5 | BlackRock, Inc. | 799K | $2.2M | +0.3% | 1.214% | 0.00% |
| 6 | MILLENNIUM MANAGEMENT LLC | 798K | $2.2M | +239.0% | 1.212% | 0.00% |
| 7 | Wealthspire Advisors, LLC | 722K | $2.0M | +19.9% | 1.096% | 0.02% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 613K | $1.7M | +2.5% | 0.931% | 0.00% |
| 9 | TWO SIGMA INVESTMENTS, LP | 467K | $1.3M | +2711.6% | 0.709% | 0.00% |
| 10 | COMMONWEALTH EQUITY SERVICES, LLC | 367K | $1.0M | +9.9% | 0.557% | 0.00% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 304K | $849K | β | 0.462% | 0.00% |
| 12 | LPL Financial LLC | 267K | $745K | -17.8% | 0.406% | 0.00% |
| 13 | Vivaldi Capital Management, LLC | 259K | $721K | +26.7% | 0.393% | 0.10% |
| 14 | STATE STREET CORP | 258K | $721K | +6.7% | 0.392% | 0.00% |
| 15 | Geneos Wealth Management Inc. | 241K | $672K | -1.0% | 0.366% | 0.02% |
| 16 | Sovran Advisors, LLC | 258K | $585K | +14.1% | 0.392% | 0.05% |
| 17 | RETIREMENT GUYS FORMULA LLC | 187K | $522K | +1.4% | 0.284% | 0.24% |
| 18 | GOLDMAN SACHS GROUP INC | 185K | $515K | -39.9% | 0.281% | 0.00% |
| 19 | UBS Group AG | 180K | $501K | +359.6% | 0.273% | 0.00% |
| 20 | 683 Capital Management, LLC | 162K | $453K | 0.0% | 0.247% | 0.04% |
| 21 | BLAIR WILLIAM & CO/IL | 149K | $417K | +294.1% | 0.227% | 0.00% |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 148K | $413K | β | 0.225% | 0.00% |
| 23 | NORTHERN TRUST CORP | 130K | $364K | 0.0% | 0.198% | 0.00% |
| 24 | Qube Research & Technologies Ltd | 126K | $353K | +69.4% | 0.192% | 0.00% |
| 25 | BARCLAYS PLC | 112K | $312K | +5.1% | 0.170% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in GALT β a direct measure of their conviction.
Filings activity in GALT during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 95 | +1.1% | 21.54% | 6.77 pp | $38M | 24% |
| Q4 2025 | 94 | +15% | 28.31% | +4.82 pp | $50M | +21% |
| Q3 2025 | 82 | 2.4% | 23.49% | +12.21 pp | $41M | +108% |
| Q2 2025 | 84 | 8.7% | 11.28% | +4.36 pp | $20M | +63% |
| Q1 2025 | 92 | +0.0% | 6.92% | 2.51 pp | $12M | 27% |
| Q4 2024 | 92 | +15% | 9.43% | 5.23 pp | $17M | 36% |
| Q3 2024 | 80 | +9.6% | 14.66% | +2.17 pp | $26M | +17% |
| Q2 2024 | 73 | β | 12.49% | β | $22M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying GALT stock.
Based on Q1 2026 13F filings, institutional ownership of Galectin Therapeutics Inc. stands at 21.5%, held across 95 reporting institutions.
VANGUARD CAPITAL MANAGEMENT LLC is the largest reported institutional holder of GALT, with approximately 1,966,542 shares worth $0.01B as of Q1 2026.
Yes β 4 widely-followed marquee investors appear among the top 25 institutional holders of GALT, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for GALT is 51 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
20 institutions opened new positions in GALT during Q1 2026, while 19 fully exited. 12 added to existing positions and 63 trimmed.
GALT institutional ownership fell by 6.77 percentage points quarter-over-quarter, with a net change of +1 holders.
The top 10 institutions account for 67.4% of all reported 13F value in GALT, and the top 25 account for 88.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Galectin Therapeutics Inc. (GALT) Institutional Ownership